Type 2 Diabetes Patients With Long-Standing Disease Achieved Glycemic Control When BYETTA(R) Was Added To Lantus(R)
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced results from the first double-blind, placebo-controlled clinical study to evaluate BYETTA® (exenatide) injection added to Lantus® (insulin glargine), which showed patients with type 2 diabetes achieved glucose targets without weight gain or increasing their risk of hypoglycemia. These findings were …
Read more on Medical News Today
Tags : Achieved, Added, BYETTAR, Control, diabetes, disease, glycemic, LantusR, LongStanding, patients, type
File under : Uncategorized
Permalink : http://diabetes-type-1.org/uncategorized/type-2-diabetes-patients-with-long-standing-disease-achieved-glycemic-control-when-byettar-was-added-to-lantusr
Trackback : http://diabetes-type-1.org/uncategorized/type-2-diabetes-patients-with-long-standing-disease-achieved-glycemic-control-when-byettar-was-added-to-lantusr/trackback
Leave a Reply